VitaNova Life Sciences annual revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
VitaNova Life Sciences Revenue Growth & History (VNOV)
VitaNova Life Sciences reported $3.0M in revenue for fiscal 2026, an increase of 13.65% from the previous fiscal year.
View full VitaNova Life Sciences company overviewVitaNova Life Sciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $3.0M | $363,433 | +13.65% |
| 2025 | 2025-04-30 | $2.7M | $2.1M | +366.47% |
| 2024 | 2024-04-30 | $570,694 | $532,694 | +1401.83% |
| 2023 | 2023-04-30 | $38,000 | −$82,000 | −68.33% |
| 2022 | 2022-04-30 | $120,000 | $120,000 | — |
| 2021 | 2021-04-30 | $0 | $0 | — |
| 2020 | 2020-04-30 | $0 | $0 | — |
| 2019 | 2019-04-30 | $0 | $0 | — |
| 2018 | 2018-04-30 | $0 | — | — |
| 2017 | 2017-01-25 | $0 | — | — |
VitaNova Life Sciences quarterly revenue
Q2.18
Q3.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $1.8M | −$168,293 | −8.62% |
| Q3 2026 | 2026-01-31 | $709,625 | $401,307 | +130.16% |
| Q2 2026 | 2025-10-31 | $427,115 | $134,997 | +46.21% |
| Q1 2026 | 2025-07-31 | $103,899 | −$4,578 | −4.22% |
| Q4 2025 | 2025-04-30 | $2.0M | $1.4M | +258.65% |
| Q3 2025 | 2025-01-31 | $308,318 | $282,218 | +1081.30% |
| Q2 2025 | 2024-10-31 | $292,118 | $292,118 | — |
| Q1 2025 | 2024-07-31 | $108,477 | $108,477 | — |
| Q4 2024 | 2024-04-30 | $544,594 | $541,594 | +18053.13% |
| Q3 2024 | 2024-01-31 | $26,100 | $16,100 | +161.00% |
| Q2 2024 | 2023-10-31 | $0 | −$10,000 | −100.00% |
| Q1 2024 | 2023-07-31 | $0 | −$15,000 | −100.00% |
| Q4 2023 | 2023-04-30 | $3,000 | −$42,000 | −93.33% |
| Q3 2023 | 2023-01-31 | $10,000 | −$20,000 | −66.67% |
| Q2 2023 | 2022-10-31 | $10,000 | −$35,000 | −77.78% |
| Q1 2023 | 2022-07-31 | $15,000 | $15,000 | — |
| Q4 2022 | 2022-04-30 | $45,000 | $45,000 | — |
| Q3 2022 | 2022-01-31 | $30,000 | $30,000 | — |
| Q2 2022 | 2021-10-31 | $45,000 | $45,000 | — |
| Q1 2022 | 2021-07-31 | $0 | $0 | — |
| Q4 2021 | 2021-04-30 | $0 | $0 | — |
| Q3 2021 | 2021-01-31 | $0 | $0 | — |
| Q2 2021 | 2020-10-31 | $0 | $0 | — |
| Q1 2021 | 2020-07-31 | $0 | $0 | — |
| Q4 2020 | 2020-04-30 | $0 | $0 | — |
| Q3 2020 | 2020-01-31 | $0 | $0 | — |
| Q2 2020 | 2019-10-31 | $0 | $0 | — |
| Q1 2020 | 2019-07-31 | $0 | $0 | — |
| Q4 2019 | 2019-04-30 | $0 | $66,730 | +100.00% |
| Q3 2019 | 2019-01-31 | $0 | $0 | — |
| Q2 2019 | 2018-10-31 | $0 | −$48,330 | −100.00% |
| Q1 2019 | 2018-07-31 | $0 | −$18,400 | −100.00% |
| Q4 2018 | 2018-04-30 | −$66,730 | — | — |
| Q3 2018 · Jan 31 | 2018-01-31 | $0 | — | — |
| Q3 2018 · Oct 31 | 2017-10-31 | $48,330 | — | — |
| Q2 2018 | 2017-07-31 | $18,400 | — | — |
VitaNova Life Sciences revenue growth trends
VitaNova Life Sciences's latest reported quarter, Q4 2026, generated $1.8M in revenue, a decrease of 8.62% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review VitaNova Life Sciences source filings ↗